Usefulness of Serial N-Terminal Pro–B-Type Natriuretic Peptide Measurements for Determining Prognosis in Patients With Pulmonary Arterial Hypertension
- 1 December 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 108 (11), 1645-1650
- https://doi.org/10.1016/j.amjcard.2011.07.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hemodynamic Determinants of Myocardial B-Type Natriuretic Peptide ReleaseHypertension, 2010
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Prognosis of Pulmonary Arterial HypertensionCirculation, 2010
- Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)Journal of the American College of Cardiology, 2008
- Serial Measurements of Plasma B-Type Natriuretic Peptides: What Do They Tell Us?Journal of the American College of Cardiology, 2008
- Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertensionEuropean Respiratory Journal, 2007
- Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of resultsAmerican Heart Journal, 2006
- N-Terminal Pro-B-Type Natriuretic Peptide as an Indicator of Disease Severity in a Heterogeneous Group of Patients With Chronic Precapillary Pulmonary HypertensionThe American Journal of Cardiology, 2006
- Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001Rheumatology, 2005